FTC Wants the Skinny on Hoodia Weight Loss Claims: Charges Defendants with False Advertising for Diet Supplement Claims
April 29th, 2009
On the heels of releasing its new advertising guidelines, the FTC is wasting no time in going after individuals and companies it believes have crossed the line in their advertising practices.
Long a thorn in the side of the FTC, the weight loss market is taking the first hit. Last month, the FTC sought injunctive relief against Stella labs, Neutraceuticals International, and their principles (“Defendants”) for false advertising claims related to products it sold containing – or purporting to contain – the ingredient “Hoodia.”
Hoodia is a succulent plant found in parts of Africa, including South Africa, Botswana, and Namibia. No scientific data suggests it is an appetite supplement, but it is colloquially rumored to suppress the appetite of those who chew it. Hoodia is considered endangered by The Convention of International Trade in Endangered Species of Wild Fauna and Flora and thus its import to the U.S. is heavily regulated. According to the complaint, the only country allowed to export authentic Hoodia is South Africa.
The complaint alleges the Defendants supplied their trade customers with advertising documentation stating or implying their products contained authentic Hoodia, further representing that Hoodia caused substantial weight loss, and claiming Hoodia was an effective treatment for obesity. Based upon these representations, trade customers bought the product and resold it to consumers. None of those claims, says the FTC, had been substantiated at the time the statements were made; moreover, all of the claims, now tested, are false.
Notwithstanding the FTC’s issuing of new advertising guidelines, this complaint does not invoke the higher scrutiny contemplated by the new guidelines. These claims fall squarely into the category of false statements. Unless the Defendants can prove either the truth of their representations, or that at the time the representations were made they were true, the court will make quick work of this matter.
Practice Note: We see it all the time: a client tells us its product is scientifically proven to lose weight. It may even show us the proof. When we probe further, we discover that in fact, the evidence is not about its product, but a single ingredient in the product that has been shown to help lose weight, in certain amounts, and under certain circumstances. In fact, the product has not been proven to lose weight at all. Notwithstanding third party evidence supporting weight loss for an ingredient, a company may not glom on to those results when it sells its own product.
Although we believe it’s unlikely, under the new guidelines yet to be enforced, the FTC might well be able to pursue claims against resellers of the product too, particularly if they are paid through an incentive program. While we have seen no cases on this, the rationale is to hold third parties responsible for reselling products using the same false claims without conducting sufficient due diligence to determine whether the claims are accurate. We believe if the FTC did begin to enforce against resellers, the enforcement would begin with claims the reseller clearly knew or should have known were false.
Follow Tsan’s Legal Updates on
or Subscribe to the Cobalt Blog





















